Artelo Biosciences to Feature at H.C. Wainwright Conference
![Artelo Biosciences to Feature at H.C. Wainwright Conference](https://investorshangout.com/images/blog/ihnews-Artelo%20Biosciences%20to%20Feature%20at%20H.C.%20Wainwright%20Conference.jpg)
Artelo Biosciences to Participate in Key Investment Conference
Artelo Biosciences, Inc. (Nasdaq: ARTL), a company dedicated to combating various medical conditions through innovative therapeutics, is gearing up to present at the H.C. Wainwright 26th Annual Global Investment Conference. This annual event is set to take place from September 9 to 11, 2024, at the prestigious Lotte New York Palace Hotel.
Key Speaker Announcement
Gregory D. Gorgas, the CEO of Artelo, will be representing the company. His participation underscores Artelo's commitment to engaging with investors and showcasing the progress of their clinical-stage pharmaceutical programs aimed at treating serious health issues like cancer, pain, and neurological disorders.
Availability of Presentation
The presentation will be available for on-demand viewing to registered attendees starting from September 9, 2024. This flexibility allows investors and stakeholders to access important information about Artelo’s advancements at their convenience. They can also view the webcast of the presentation via Artelo’s official channels.
Connecting with Investors
Throughout the conference, the management team will hold one-on-one meetings with qualified investors. This initiative allows for personal interaction and provides a platform for addressing questions and details about Artelo’s innovative approaches in the pharmaceutical industry. Anyone wishing to arrange a meeting can reach out directly via the company’s investor relations email.
About Artelo Biosciences
Founded with the mission of developing cutting-edge treatments, Artelo Biosciences is focused on lipid-signaling pathways that play critical roles in various conditions, including anorexia, anxiety, inflammation, and dermatologic issues. The skilled team at Artelo comprises seasoned biopharmaceutical experts who work synergistically with researchers to create robust therapeutic solutions that meet crucial healthcare needs.
Ongoing Research and Development
The company's portfolio showcases product candidates designed to impact serious health challenges. With a proactive approach to scientific research, regulatory compliance, and commercial strategies, Artelo aims to bring significant therapies to market that address conditions often considered inadequately treated.
Investor Relations and Contact Information
For more insights into Artelo's strategic initiatives, investors can visit the company’s website or connect via social media. The dedicated investor relations team remains available to assist with inquiries, ensuring transparent communication with stakeholders.
Investor Relations Contact:
Crescendo Communications, LLC
Tel: 212-671-1020
Email: ARTL@crescendo-ir.com
Frequently Asked Questions
What is the focus of Artelo Biosciences?
Artelo Biosciences focuses on developing treatments for conditions such as cancer, pain syndromes, and dermatological issues through modulation of lipid-signaling pathways.
Who will represent Artelo at the conference?
Gregory D. Gorgas, the CEO, will be the key representative at the H.C. Wainwright Conference.
Is the presentation available for all attendees?
Yes, the presentation will be available on-demand to all registered attendees starting September 9, 2024.
How can I request a one-on-one meeting with Artelo?
Interested parties can request meetings through the investor relations email provided by Artelo.
Where can I find more information about Artelo?
Additional information can be found on Artelo’s official website and their Twitter page under @ArteloBio.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Stock Market Update: Investors Shift Focus to Rate Cuts
- Investing in Dividend Stocks: Kinder Morgan, Dominion, Southern
- Felo AI Launch: Transforming Search with Language Innovation
- The Abbey Food & Bar Earns Safe Space Certification from SIGBI
- College of Charleston Unveils Renovated Albert Simons Center
- ASLA Unveils Transformative 2024 Professional Awards Winners
- Growth of the Packaging Automation Market Towards 2032
- Chemical Injection Pumps Market Growth Expected at 8.4% CAGR
- Projected Growth of Conductive Polymer Coating Market
- Earn Alliance Appoints Jeff Drobick as New COO to Enhance Growth
- Discover Rocko: Your Gateway to Crypto-Backed Loans
- Endeavour Mining Updates on Major Shareholder Notification
- Vishay Intertechnology Expands Haptic Feedback Actuators Range
- Moon Gaming Inc. Unveils Moon Poker: Exciting Tournaments Ahead
- J.P. Morgan Enhances Morgan Money with Kyriba Integration
- Trump Hotels Enhances Operations with BirchStreet's ReactorNet
- Accorto Regulatory Solutions Partners with GINN for Tobacco Safety
- Opus IVS DrivePro 2 Achieves Motor Top 20 Award for 2024
- Autograph Revolutionizes Sports Fandom with New Platform
- Attain Capital Welcomes Former NASA CIO Renee P. Wynn
- ICEYE and Aon Join Forces to Boost Flood and Wildfire Response
- Laurence Moroney to Speak at Info-Tech LIVE 2024 Conference
- Philadelphia Fed Initiates Search for New President Following Harker
- Greece Stock Market Update: Athens Composite Dips Slightly
- Israel Stock Exchange Overview: TA 35 Declines Amid Sectors
Recent Articles
- Centene's Iowa Total Care Awarded New Medicaid Contract
- American Financial Resources Announces Key Executive Changes
- Yaber Unveils K3 Series Home Theatre Projector at IFA 2024
- Exciting Premier of 'Mutual of Omaha's Wild Kingdom Protecting the Wild'
- GT Metabolic™ Solutions Achieves FDA Approval for MagDI™ System
- Blue Circle Health Launches New T1D Program in Northern States
- Sumeet Chabria Joins Genesis as Senior Advisor for Growth
- Explore Einstein Bros. Bagels' New Fall Flavor Fling Combo
- Volvo Cars Enhances XC90 Hybrid Amid Electric Shift
- John Bonasera Joins Blue Matter, Enhancing Strategic Expertise
- Acer Launches Predator XB273U F5 Gaming Monitor with G-SYNC
- MEMS Electronic Oscillators Market Growth Driven by 5G Tech
- Mullen Automotive Begins Shipping EVs Under Major Contract
- Stitch Fix Welcomes Timothy Baxter and Fiona Tan to Board
- PennantPark Floating Rate Capital Ltd. Declares Monthly Dividend
- Big Wave Systems Partners with CMS for Health Insurance Support
- Exploring the Growing Polyurethane Market: Trends and Insights
- Green Logistics Market Surge: Growth to Reach USD 3.11 Trillion
- Midi Health and Mount Sinai Team Up for Menopause Care Access
- Arctic Blue Fish Oil: Essential DHA and EPA for Moms-to-Be
- Uruguay's Tender Offer Results and Bond Purchasing Details
- Highland Copper Welcomes Wynand van Dyk as Project Director
- XOMA Royalty Corporation: Key Investor Conferences in September
- Koryx Copper Welcomes New Leadership to Accelerate Growth
- Albion Enterprise VCT PLC AGM Insights and Resolutions Passed